Search results
- Simply Wall St. via Yahoo
Regeneron Pharmaceuticals (NASDAQ:REGN) stock performs better than its underlying earnings growth over last five years
NasdaqGS:REGN Earnings Per Share Growth July 14th 2024 Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here. A Different Perspective ...
3 days ago
- Investing.com
UBS bumps Regeneron Pharma stock price target on growth potential By Investing.com
On Friday, UBS increased its price target for Regeneron (NASDAQ:REGN) Pharmaceuticals (NASDAQ: REGN), setting the new mark at $1,250 up from the previous $1,124, while reaffirming its Buy rating ...
5 days ago